Inequality Has Never Been Bigger: Financial Assets Hit A Record 620% Of GDP
Intranasal vaccine platform has potential for more effective vaccines, fewer side effects
Pfizer to make Gilead’s COVID-19 treatment remdesivir
Vaccines through microneedle skin patches
Groupon Soars 28% In Pre-Market On Stellar 2Q Beat
Predictions of Things to Come
Only 42% Say They Will Submit To COVID-19 Vaccine, New Poll Finds
Three major scientific controversies about coronavirus
ServiceNow Prices $1.5B Public Offering; Moody's Assigns Baa1 Rating
Beware harm to federal health agencies
Yelp Up 5% On Q2 Beat; RBC Says Stock 'Needs A Vaccine Too'
Buy Moderna Stock as the COVID-19 Vaccine Race Heats Up, Says 5-Star Analyst
Boeing’s Inventory Surplus Could Be Good for Free Cash Flow, Says Analyst
3 "Strong Buy" Healthcare Stocks Under $5 That Could See Outsized Gains
Dan Loeb Explains Why He Went Long Amazon, Disney In The Quarter He Returned As CIO
3 Healthcare Stocks Under $5 That Could See Outsized Gains
Video: What the huge COVID-19 testing undercount in the US means
Dan Loeb Opens New Chinese Equity Positions In Q2 Letter
Fauci expects tens of millions of coronavirus vaccine doses at start of 2021
A second COVID-19 wave? Here are 6 lessons from the first
Senator Mitch McConnell says a deal will come together ‘in the near future’
Bausch Health To Spin Off Eye Care Business; Shares Surge 18%
Initial and continuing jobless claims: back to being “less awful”
Novavax says COVID-19 vaccine could be approved by year-end
Pondering Negative Real Yields And Higher Inflation Forecasts
Company earnings – There is room for upside, but mind the risks
Moderna prices COVID-19 vaccine at $32-$37 per dose for smaller volume deals
Novavax coronavirus vaccine induces immune response in early study
The Media Said Europe "Beat Back" COVID, But Now Lockdowns Loom Again
NYC Sets Up "Check Points" For Travelers; NJ Complains COVID-19 Positivity Rate Is "Too High": Live Updates